Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACC's 57th Annual Scientif...( Presentation by Leader of Innovativ...),Health

Presentation by Leader of Innovative Scripps Genomic Medicine Program to

Include Data on Novel Genomic Markers for Cardiac Disease

SAN DIEGO, March 26 /PRNewswire/ -- Eric J. Topol, M.D., chief academic officer of Scripps Health and director of the Scripps Translational Science Institute, will present a late-breaking lecture about advancements in the genomics of cardiovascular disease at the American College of Cardiology's (ACC) 57th Annual Scientific Session in Chicago.

Dr. Topol's presentation on March 31 will include data concerning new, compelling genomic markers for myocardial infarction, coronary artery disease, atrial fibrillation and abnormal lipoproteins. A panel discussion about the progress, limitations, caveats and future issues in cardiovascular genomic medicine will follow the presentation.

Who: Eric J. Topol, M.D., Chief Academic Officer, Scripps Health;

Director of Scripps Translational Science Institute; Professor of

Translational Genomics, The Scripps Research Institute

What: Late-breaking lecture about advancements in the genomics of

cardiovascular disease

When: 3:30 p.m.-4:30 p.m. CDT, March 31

Where: North Hall B1, McCormick Place, Chicago

About Scripps Genomic Medicine

An initiative of Scripps Health and The Scripps Research Institute, Scripps Genomic Medicine is an innovative program in which genomic researchers, clinicians and other specialists are working side-by-side to advance medicine. Current projects include the genotyping of tens of thousands of individuals of diverse ancestry to identify and define genes that are responsible for major disease and the underpinnings of health. Through The Scripps Translational Science Institute, this basic research will be translated into drug discovery programs and, ultimately, clinical trials. These trials, launched through Scripps Advanced Clinical Trials, will test
'/>"/>